Cagrilintide 10 mg – Long-Acting Amylin Analogue for Research
Cagrilintide 10 mg is a synthetic, long-acting analogue of the naturally occurring peptide hormone amylin. Its specialised lipidated structure includes a fatty-acid side chain that supports reversible albumin binding, improved molecular stability and a prolonged research profile compared with native amylin.
This advanced research compound is studied in laboratory environments focusing on amylin and calcitonin receptor activity, satiety-related signalling, metabolic pathways, energy balance and long-acting peptide development. Its distinctive molecular design makes Cagrilintide particularly relevant for researchers examining receptor pharmacology, peptide engineering and metabolic signalling.
Each vial contains 10 mg of Cagrilintide in lyophilised powder form and is securely packaged to help protect product integrity during storage and transportation.
Key Product Features
- 10 mg of Cagrilintide per vial
- Synthetic long-acting amylin analogue
- Lyophilised research material
- Lipidated structure with a fatty-acid side chain
- Designed for extended molecular stability
- Relevant for receptor and metabolic pathway research
- Suitable for analytical and comparative laboratory studies
- Secure and discreet packaging
- Clear product and batch information
What Is Cagrilintide?
Cagrilintide is a modified analogue of amylin, a naturally occurring peptide hormone involved in physiological signalling related to satiety, food intake and post-meal metabolic regulation.
Native amylin has a relatively short duration of activity and can present challenges related to stability. Cagrilintide has therefore been developed with structural modifications that support a longer-lasting molecular profile.
The addition of a fatty-acid side chain promotes reversible albumin binding. This type of molecular modification is widely studied in peptide research because it can help reduce rapid clearance and extend the period during which a compound remains available for analysis.
Research Applications
Cagrilintide 10 mg may be relevant for controlled laboratory research involving:
- Amylin receptor activity
- Calcitonin receptor signalling
- Receptor-binding characteristics
- Satiety-related signalling pathways
- Appetite and food-intake research
- Metabolic pathway interactions
- Energy-balance mechanisms
- Glucose-homeostasis research
- Gastric-emptying pathways
- Pancreatic hormone signalling
- Neuroendocrine communication
- Peptide lipidation
- Albumin-binding mechanisms
- Molecular stability studies
- Long-acting peptide development
- Comparative receptor pharmacology
- Analytical peptide characterisation
These research areas describe scientific interest and do not represent approved therapeutic applications.
Advanced Molecular Structure
Cagrilintide belongs to the category of lipidated peptide analogues. Its molecular structure is designed to support greater stability and a longer duration of activity than native amylin.
Important structural characteristics include:
- Synthetic amylin-based peptide structure
- Fatty-acid side-chain modification
- Reversible albumin-binding properties
- Improved resistance to rapid clearance
- Extended molecular exposure
- Activity involving amylin and calcitonin receptor systems
- Relevance for long-acting peptide research
These characteristics make Cagrilintide an interesting compound for researchers studying how structural modifications can influence peptide stability, receptor interaction and pharmacokinetic behaviour.
Receptor Research
Cagrilintide is studied in relation to receptors within the calcitonin receptor family. Amylin receptors are formed through interactions between the calcitonin receptor and receptor activity-modifying proteins.
Laboratory studies may examine:
- Receptor affinity
- Receptor activation
- Intracellular signalling
- Ligand-receptor interactions
- Concentration-response relationships
- Receptor internalisation
- Comparative activity across receptor systems
- Differences between native amylin and modified analogues
The exact experimental method, controls and analytical procedures should be established by the qualified laboratory conducting the research.
Product Specifications
| Product characteristic |
Information |
| Product name |
Cagrilintide |
| Amount |
10 mg |
| Product category |
Synthetic research peptide |
| Compound type |
Long-acting amylin analogue |
| Form |
Lyophilised powder |
| Molecular modification |
Lipidated peptide with a fatty-acid side chain |
| Research focus |
Amylin and calcitonin receptor activity |
| Packaging |
Sealed research vial |
| Intended use |
Scientific and laboratory research |
Product Appearance
Cagrilintide 10 mg is supplied as a lyophilised research material in a sealed vial. The appearance of lyophilised peptides may vary slightly depending on production conditions, quantity and residual moisture.
Physical appearance alone should not be used to determine product identity or quality. Researchers should always review the available product and batch information before beginning laboratory analysis.
Storage Information
Store Cagrilintide in a cool, dry and dark environment in accordance with the information provided with the product.
Protect the vial from:
- Direct sunlight
- Excessive heat
- Moisture
- Contamination
- Repeated temperature changes
- Unnecessary exposure to air
The receiving laboratory is responsible for establishing suitable handling, preparation and storage procedures for its specific research protocol.
Why Choose Peptides Divas?
Peptides Divas supplies carefully presented research compounds with a focus on clear product information, secure packaging and professional order processing.
Customers benefit from:
- Clearly displayed product specifications
- Secure and discreet packaging
- Traceable shipping options
- Professional customer support
- Fast order processing
- A carefully selected research catalogue
- Clear laboratory-use information
Order Cagrilintide 10 mg from Peptides Divas for advanced laboratory research involving amylin signalling, receptor activity, metabolic pathways and long-acting peptide development.
For laboratory research use only. Not intended for human or veterinary use.
